Stoke Therapeutics, Inc. announced the appointment of Julie Anne Smith to its Board of Directors. Ms. Smith has also been appointed to the Compensation Committee of the Board of Directors. Ms. Smith will replace Samuel Hall, whose term on the Board of Directors expired. Ms. Smith currently serves as President and CEO of ESCAPE Bio, Inc.